Mechanisms of Cellular Activation in the Antiphospholipid Syndrome

Abstract It is long known that antiphospholipid antibodies (aPL) induce proinflammatory and procoagulant cellular responses. The underlying signal transduction has been a major focus of research and is the topic of this review. An amazingly heterogeneous panel of signaling pathways has been described and it turns out that at least some of this heterogeneity can be explained by effects of distinct aPL species. On the one hand, there are antibodies against β2-glycoprotein I (β2GPI) which appear to exert their cellular effects only as a complex of β2GPI/anti-β2GPI. Their major targets are low-density lipoprotein-receptor related protein 8 (LRP8), annexin A2 (ANXA2), toll-like receptor 4 (TLR4), and possibly TLR2. The other relevant aPL species are antibodies against cardiolipin which are internalized into endosomes and induce cellular responses via activation of endosomal NADPH-oxidase. Their cell surface target is still unknown. Another important issue relates to the role of complement. It has been shown in vivo that certain pathogenic effects of aPL depend on complement activation, but the exact interplay with the signaling pathways described earlier needs to be elucidated. Thus, while there has been tremendous progress over the past decade, many open questions remain to be answered.

[1]  K. McCrae,et al.  Extracellular Vesicles in the Antiphospholipid Syndrome , 2017, Seminars in Thrombosis and Hemostasis.

[2]  U. Walter,et al.  Cofactor‐independent human antiphospholipid antibodies induce venous thrombosis in mice , 2016, Journal of thrombosis and haemostasis : JTH.

[3]  C. Mineo,et al.  ApoE Receptor 2 Mediation of Trophoblast Dysfunction and Pregnancy Complications Induced by Antiphospholipid Antibodies in Mice , 2016, Arthritis & rheumatology.

[4]  G. Canaud,et al.  AKT/mTORC pathway in antiphospholipid-related vasculopathy: a new player in the game , 2015, Lupus.

[5]  K. Lackner,et al.  Cofactor-independent antiphospholipid antibodies activate the NLRP3-inflammasome via endosomal NADPH-oxidase: implications for the antiphospholipid syndrome , 2015, Thrombosis and Haemostasis.

[6]  D. Isenberg,et al.  Proof-of-concept study demonstrating the pathogenicity of affinity-purified IgG antibodies directed to domain I of β2-glycoprotein I in a mouse model of anti-phospholipid antibody-induced thrombosis , 2014, Rheumatology.

[7]  J. Chapman,et al.  IgG accumulates in inhibitory hippocampal neurons of experimental antiphospholipid syndrome. , 2014, Journal of autoimmunity.

[8]  V. Richard,et al.  Role of Toll‐like Receptors 2 and 4 in Mediating Endothelial Dysfunction and Arterial Remodeling in Primary Arterial Antiphospholipid Syndrome , 2014, Arthritis & rheumatology.

[9]  C. Mineo,et al.  Genetic variants of ApoE and ApoER2 differentially modulate endothelial function , 2014, Proceedings of the National Academy of Sciences.

[10]  B. Furie,et al.  Platelets are required for enhanced activation of the endothelium and fibrinogen in a mouse thrombosis model of APS. , 2014, Blood.

[11]  E. Kruithof,et al.  NF‐κB is activated from endosomal compartments in antiphospholipid antibodies‐treated human monocytes , 2014, Journal of thrombosis and haemostasis : JTH.

[12]  N. Beglova,et al.  Inhibition of thrombotic properties of persistent autoimmune anti-β2GPI antibodies in the mouse model of antiphospholipid syndrome. , 2014, Blood.

[13]  Hong Zhou,et al.  The role of TLR4 in pathophysiology of antiphospholipid syndrome‐associated thrombosis and pregnancy morbidity , 2014, British journal of haematology.

[14]  G. Canaud,et al.  Inhibition of the mTORC pathway in the antiphospholipid syndrome. , 2014, The New England journal of medicine.

[15]  Kazuo Umezawa,et al.  The NF-κB specific inhibitor DHMEQ prevents thrombus formation in a mouse model of antiphospholipid syndrome. , 2013, Journal of nephropathology.

[16]  D. Waisman,et al.  Annexin A2 Heterotetramer: Structure and Function , 2013, International journal of molecular sciences.

[17]  K. Lackner,et al.  Endosomal NADPH-oxidase is critical for induction of the tissue factor gene in monocytes and endothelial cells , 2013, Thrombosis and Haemostasis.

[18]  G. Valesini,et al.  Autoantibodies specific to a peptide of β2-glycoprotein I cross-react with TLR4, inducing a proinflammatory phenotype in endothelial cells and monocytes. , 2012, Blood.

[19]  G. Vargas,et al.  C6 knock-out mice are protected from thrombophilia mediated by antiphospholipid antibodies , 2012, Lupus.

[20]  H. Schild,et al.  A Role for Toll-Like Receptor Mediated Signals in Neutrophils in the Pathogenesis of the Anti-Phospholipid Syndrome , 2012, PloS one.

[21]  P. Massari,et al.  The Role of TLR2 in Infection and Immunity , 2012, Front. Immun..

[22]  I. Giles,et al.  Examining how antiphospholipid antibodies activate intracellular signaling pathways: a systematic review. , 2012, Seminars in arthritis and rheumatism.

[23]  K. McCrae,et al.  A novel pathway for human endothelial cell activation by antiphospholipid/anti-β2 glycoprotein I antibodies. , 2012, Blood.

[24]  H. Schild,et al.  Antiphospholipid antibodies induce translocation of TLR7 and TLR8 to the endosome in human monocytes and plasmacytoid dendritic cells. , 2011, Blood.

[25]  E. Kruithof,et al.  Toll-like receptor 2 mediates the activation of human monocytes and endothelial cells by antiphospholipid antibodies. , 2011, Blood.

[26]  B. Furie,et al.  β₂-Glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model. , 2011, Blood.

[27]  P. D. de Groot,et al.  Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome. , 2011, Blood.

[28]  P. D. de Groot,et al.  Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2. , 2011, The Journal of clinical investigation.

[29]  P. D. de Groot,et al.  The association between circulating antibodies against domain I of beta2‐glycoprotein I and thrombosis: an international multicenter study , 2009, Journal of thrombosis and haemostasis : JTH.

[30]  K. Hajjar,et al.  Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo. , 2009, Blood.

[31]  C. Sommer,et al.  In Vitro Effects of Antiphospholipid Syndrome‐IgG Fractions and Human Monoclonal Antiphospholipid IgG Antibody on Human Umbilical Vein Endothelial Cells and Monocytes , 2009, Annals of the New York Academy of Sciences.

[32]  J. Brosens,et al.  ORIGINAL ARTICLE: Antiphospholipid Antibodies Induce a Pro‐Inflammatory Response in First Trimester Trophoblast Via the TLR4/MyD88 Pathway , 2009, American journal of reproductive immunology.

[33]  E. Topol,et al.  Deficiency of LRP8 in mice is associated with altered platelet function and prolonged time for in vivo thrombosis. , 2009, Thrombosis research.

[34]  Hiroshi Deguchi,et al.  Activated protein C ligation of ApoER2 (LRP8) causes Dab1-dependent signaling in U937 cells , 2009, Proceedings of the National Academy of Sciences.

[35]  K. McCrae,et al.  Annexin A2: biology and relevance to the antiphospholipid syndrome , 2008, Lupus.

[36]  N. Mackman,et al.  Tissue factor in antiphospholipid antibody-induced pregnancy loss: a pro-inflammatory molecule , 2008, Lupus.

[37]  P. Meroni,et al.  Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome , 2008, Lupus.

[38]  N. Mackman,et al.  Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome. , 2008, The Journal of clinical investigation.

[39]  R. Derksen,et al.  Platelet activation by dimeric β2‐glycoprotein I requires signaling via both glycoprotein Ibα and apolipoprotein E receptor 2′ , 2008, Journal of thrombosis and haemostasis : JTH.

[40]  H. Xiong,et al.  Endothelial Cell Annexin A2 Regulates Polyubiquitination and Degradation of Its Binding Partner S100A10/p11* , 2008, Journal of Biological Chemistry.

[41]  P. D. de Groot,et al.  Current insight into diagnostics and pathophysiology of the antiphospolipid syndrome. , 2008, Blood reviews.

[42]  L. Wei,et al.  Annexin A2 Regulates the Levels of Plasmin, S100A10 and Fascin in L5178Y Cells , 2008, Cancer investigation.

[43]  G. Valesini,et al.  Anti-β2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor α and tissue factor by signal transduction pathways involving lipid rafts , 2007 .

[44]  R. Derksen,et al.  Platelets express three different splice variants of ApoER2 that are all involved in signaling , 2007, Journal of thrombosis and haemostasis : JTH.

[45]  S. Pierangeli,et al.  C5a Receptor‐Deficient Mice Are Protected from Thrombophilia and Endothelial Cell Activation Induced by Some Antiphospholipid Antibodies , 2007, Annals of the New York Academy of Sciences.

[46]  P. D. de Groot,et al.  Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5. , 2007, Blood.

[47]  E. Kruithof,et al.  The role of TLR2 in the inflammatory activation of mouse fibroblasts by human antiphospholipid antibodies. , 2007, Blood.

[48]  Xiaowei Liu,et al.  Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies , 2007, Annals of the rheumatic diseases.

[49]  P. May,et al.  The LDL receptor‐related protein (LRP) family: An old family of proteins with new physiological functions , 2007, Annals of medicine.

[50]  B. Božič,et al.  Annexin A5 binding to giant phospholipid vesicles is differentially affected by anti-beta2-glycoprotein I and anti-annexin A5 antibodies. , 2007, Rheumatology.

[51]  Hong Zhou,et al.  Involvement of annexin A2 in anti-beta2GPI/beta2GPI-induced tissue factor expression on monocytes. , 2007, Cell research.

[52]  G. Valesini,et al.  Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts. , 2007, Arthritis and rheumatism.

[53]  N. Laird,et al.  Polymorphism in maternal LRP8 gene is associated with fetal growth. , 2006, American journal of human genetics.

[54]  W. Schneider,et al.  Reconstitution of the Reelin Signaling Pathway in Fibroblasts Demonstrates that Dab1 Phosphorylation Is Independent of Receptor Localization in Lipid Rafts , 2006, Molecular and Cellular Biology.

[55]  Xiaowei Liu,et al.  Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia. , 2005, Arthritis and rheumatism.

[56]  K. McCrae,et al.  Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies. , 2005, Blood.

[57]  P. D. de Groot,et al.  IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. , 2005, Blood.

[58]  S. Akira,et al.  Toll-like receptor downstream signaling , 2004, Arthritis research & therapy.

[59]  E. Svenungsson,et al.  Decreased Binding of Annexin V to Endothelial Cells: A Potential Mechanism in Atherothrombosis of Patients With Systemic Lupus Erythematosus , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[60]  J. Salmon,et al.  Heparin prevents antiphospholipid antibody–induced fetal loss by inhibiting complement activation , 2004, Nature Medicine.

[61]  S. Akira,et al.  Functions of toll-like receptors: lessons from KO mice. , 2004, Comptes rendus biologies.

[62]  S. Pierangeli,et al.  Intracellular signaling triggered by antiphospholipid antibodies in platelets and endothelial cells: a pathway to targeted therapies. , 2004, Thrombosis research.

[63]  J. Lambris,et al.  Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. , 2003, The Journal of clinical investigation.

[64]  P. D. de Groot,et al.  Dimers of β2-Glycoprotein I Increase Platelet Deposition to Collagen via Interaction with Phospholipids and the Apolipoprotein E Receptor 2′* , 2003, Journal of Biological Chemistry.

[65]  Pojen P. Chen,et al.  Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay. , 2003, The American journal of pathology.

[66]  A. Mantovani,et al.  Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. , 2003, Blood.

[67]  B. Brachvogel,et al.  Annexin A5 Is Not Essential for Skeletal Development , 2003, Molecular and Cellular Biology.

[68]  F. Velasco,et al.  The role of tissue factor in the antiphospholipid syndrome. , 2001, Arthritis and rheumatism.

[69]  B. Beutler,et al.  Identification of Toll-like receptor 4 (Tlr4) as the sole conduit for LPS signal transduction: genetic and evolutionary studies , 2001, Journal of endotoxin research.

[70]  S. Akira,et al.  Toll-like receptors: critical proteins linking innate and acquired immunity , 2001, Nature Immunology.

[71]  E. Babiychuk,et al.  Annexins in Cell Membrane Dynamics , 2000, The Journal of cell biology.

[72]  K. McCrae,et al.  High Affinity Binding of β2-Glycoprotein I to Human Endothelial Cells Is Mediated by Annexin II* , 2000, The Journal of Biological Chemistry.

[73]  G. Schmitz,et al.  Analysis of Prothrombotic Effects of two Human Monoclonal IgG Antiphospholipid Antibodies of Apparently Similar Specificity , 2000, Thrombosis and Haemostasis.

[74]  J. Hanly,et al.  Anti-beta2-glycoprotein I (GPI) autoantibodies, annexin V binding and the anti-phospholipid syndrome. , 2000, Clinical and experimental immunology.

[75]  F. Velasco,et al.  Increased Levels of Tissue Factor mRNA in Mononuclear Blood Cells of Patients with Primary Antiphospholipid Syndrome , 1999, Thrombosis and Haemostasis.

[76]  D. Riddell,et al.  rapid communication Identification and characterization of LRP8 (apoER2) in human blood platelets , 2022 .

[77]  K. Lackner,et al.  Isolation and characterization of two human monoclonal anti-phospholipid IgG from patients with autoimmune disease. , 1999, Journal of autoimmunity.

[78]  H. Schwarz,et al.  Analysis of Cd44-Containing Lipid Rafts , 1999, The Journal of cell biology.

[79]  S. Akira,et al.  Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. , 1999, Journal of immunology.

[80]  E. Rusinova,et al.  Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: a "lupus procoagulant" phenomenon. , 1998, Blood.

[81]  G. Hughes,et al.  Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes. , 1998, Arthritis and rheumatism.

[82]  F. Luan,et al.  Human anticardiolipin monoclonal autoantibodies cause placental necrosis and fetal loss in BALB/c mice. , 1998, Arthritis and rheumatism.

[83]  R. Parton,et al.  A lipid associated with the antiphospholipid syndrome regulates endosome structure and function , 1998, Nature.

[84]  Brisson,et al.  Growth of Protein 2-D Crystals on Supported Planar Lipid Bilayers Imaged in Situ by AFM. , 1998, Journal of structural biology.

[85]  N. Rote,et al.  Antiphosphatidylserine antibody removes annexin-V and facilitates the binding of prothrombin at the surface of a choriocarcinoma model of trophoblast differentiation. , 1997, American journal of obstetrics and gynecology.

[86]  J. Rand,et al.  Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism. , 1997, The New England journal of medicine.

[87]  G. Hughes,et al.  Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression. , 1997, Arthritis and rheumatism.

[88]  J. Benz,et al.  Annexins: from structure to function. , 1997, Biological chemistry.

[89]  D. Waisman,et al.  Tyrosine Phosphorylation of Annexin II Tetramer Is Stimulated by Membrane Binding* , 1997, The Journal of Biological Chemistry.

[90]  J. Barker,et al.  Thrombogenic properties of murine anti-cardiolipin antibodies induced by beta 2 glycoprotein 1 and human immunoglobulin G antiphospholipid antibodies. , 1996, Circulation.

[91]  Y. Shoenfeld,et al.  Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies. , 1994, Journal of immunology.

[92]  J. Barquinero,et al.  Effect of Human IgG Antiphospholipid Antibodies on an In Vivo Thrombosis Model in Mice , 1994, Thrombosis and Haemostasis.

[93]  W Baumeister,et al.  Three-dimensional structure of membrane-bound annexin V. A correlative electron microscopy-X-ray crystallography study. , 1994, Journal of molecular biology.

[94]  G. Rodgers,et al.  Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism of thrombosis. , 1993, American journal of obstetrics and gynecology.

[95]  H. Hemker,et al.  Clustering of lipid-bound annexin V may explain its anticoagulant effect. , 1992, The Journal of biological chemistry.

[96]  C. Tsai,et al.  Inhibition of astrocyte proliferation and binding to brain tissue of anticardiolipin antibodies purified from lupus serum. , 1992, Annals of the rheumatic diseases.

[97]  Y. Shoenfeld,et al.  Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[98]  J. Freyssinet,et al.  Sub-domain structure of lipid-bound annexin-V resolved by electron image analysis. , 1991, Journal of molecular biology.

[99]  M. Mitchell,et al.  Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss. , 1990, American journal of obstetrics and gynecology.

[100]  K. Fujikawa,et al.  Placental anticoagulant proteins: isolation and comparative characterization four members of the lipocortin family. , 1988, Biochemistry.

[101]  K. Fujikawa,et al.  Human placental anticoagulant protein: isolation and characterization. , 1987, Biochemistry.